Home / 2018 / July (page 3)

Monthly Archives: July 2018

Is There a Future for BGM?

Guest Post by David Kliff, Editor, Diabetic Investor

With each passing day, it’s becoming more apparent that CGM will replace BGM as the standard for glucose measurement. CGM systems are becoming more patient-friendly, i.e. no calibrations, simple insertion, and cheaper too. The data provided by CGM is transformative, leading to improved outcomes. It is no longer a question of if this will happen but when this will happen.

Read More »

CGM for Type 2

Would you be open to using a CGM for your type 2 patients who are not on insulin? Follow the link to share your response.

Read More »

July 24, 2018

Way back in 2002 we had an article on in our newsletter on the newly discovered INGAP peptide (http://www.diabetesincontrol.com/issue-111-item-19-ingap-peptide-an-initiator-of-beta-cell-growth/ ) This peptide was thought to be able to regenerate beta cells, and early on it looked like a possible cure. Over the past 16 years we have had multiple features on …

Read More »

Aaron Vinik 2018 Complete Interview

AARON I. VINIK, MD, PhD, FCP, MACP, FACE is a global leader in basic and clinical neuropathy. He, in essence, has defined the heterogeneity of neuropathy, established a need for a modular approach depending on the particular nerve fiber damaged, and pioneered immunotherapy for autoimmune neuropathies.  He was awarded a lifetime achievement award by EASD Neurodiab in 2011 for his contributions to the understanding of neuropathies. In 2016, he received the American College of Endocrinology (AACE) Distinction in Endocrinology Award in recognition of advancing the understanding of endocrinology through research and education.

Read More »